Hatice Aslan Sirakaya, Bekir Ayyildiz, Ibrahim Ismet Sert, Bekir Kucuk, Semra Koca, Ender Sirakaya
{"title":"The role of triglyceride-glucose index in central retinal artery occlusion.","authors":"Hatice Aslan Sirakaya, Bekir Ayyildiz, Ibrahim Ismet Sert, Bekir Kucuk, Semra Koca, Ender Sirakaya","doi":"10.1007/s10792-024-03344-x","DOIUrl":null,"url":null,"abstract":"<p><strong>Purpose: </strong>To evaluate the correlation between the Triglyceride-Glucose (TyG) index and newly diagnosed cases of central retinal artery occlusion (CRAO) in patients.</p><p><strong>Methods: </strong>The research involved 51 patients diagnosed with central retinal artery occlusion (CRAO) and a control group consisting of 50 healthy volunteers matched for age and sex. Following a thorough ocular examination, various blood biochemistry and hematological parameters were documented. The TyG index was derived from fasting plasma glucose and triglyceride values.</p><p><strong>Results: </strong>The average age was 66.1 ± 8.9 years for individuals with CRAO and 64.9 ± 7.6 years for those in the control group. Significant differences in TyG values were observed between the CRAO and control groups, with the CRAO group exhibiting higher values (8.74 ± 0.17 vs. 8.49 ± 0.22, p<0.001). Upon multivariate analysis, the TyG index emerged as an independent predictor of CRAO (Odds Ratio= 1.84, 95% confidence interval = 1.19 - 4.23; p < 0.001). In receiver operating characteristics analysis, the area under the curve for the TyG index was 0.789. A TyG index exceeding 8.58 predicted CRAO with 78% sensitivity and 68% specificity.</p><p><strong>Conclusion: </strong>The current study demonstrated a notable association between increased TyG index and central retinal artery occlusion (CRAO). Thus, the TyG index could serve as a valuable predictive marker for assessing the risk of CRAO.</p>","PeriodicalId":14473,"journal":{"name":"International Ophthalmology","volume":"45 1","pages":"82"},"PeriodicalIF":1.4000,"publicationDate":"2025-02-25","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"International Ophthalmology","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1007/s10792-024-03344-x","RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q3","JCRName":"OPHTHALMOLOGY","Score":null,"Total":0}
引用次数: 0
Abstract
Purpose: To evaluate the correlation between the Triglyceride-Glucose (TyG) index and newly diagnosed cases of central retinal artery occlusion (CRAO) in patients.
Methods: The research involved 51 patients diagnosed with central retinal artery occlusion (CRAO) and a control group consisting of 50 healthy volunteers matched for age and sex. Following a thorough ocular examination, various blood biochemistry and hematological parameters were documented. The TyG index was derived from fasting plasma glucose and triglyceride values.
Results: The average age was 66.1 ± 8.9 years for individuals with CRAO and 64.9 ± 7.6 years for those in the control group. Significant differences in TyG values were observed between the CRAO and control groups, with the CRAO group exhibiting higher values (8.74 ± 0.17 vs. 8.49 ± 0.22, p<0.001). Upon multivariate analysis, the TyG index emerged as an independent predictor of CRAO (Odds Ratio= 1.84, 95% confidence interval = 1.19 - 4.23; p < 0.001). In receiver operating characteristics analysis, the area under the curve for the TyG index was 0.789. A TyG index exceeding 8.58 predicted CRAO with 78% sensitivity and 68% specificity.
Conclusion: The current study demonstrated a notable association between increased TyG index and central retinal artery occlusion (CRAO). Thus, the TyG index could serve as a valuable predictive marker for assessing the risk of CRAO.
期刊介绍:
International Ophthalmology provides the clinician with articles on all the relevant subspecialties of ophthalmology, with a broad international scope. The emphasis is on presentation of the latest clinical research in the field. In addition, the journal includes regular sections devoted to new developments in technologies, products, and techniques.